Condition: Mild Cognitive Impairment (MCI) · Subjective Cognitive Decline (SCD) · Sponsor: Rotman Research Institute at Baycrest
The goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol in combination with cognitive training can improve cognitive abilities in older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI). The study will look at whether it is safe and tolerable to use accelerated dTMS to enhance the benefits of cognitive training in older adults, and will also gather early information on the effects of accelerated dTMS on memory and other cognitive abilities.
This description comes directly from the study's public registry record.
Amanda Chao, MPH · 416-785-2500 · preventad@research.baycrest.org
Linda Mah, MD · 416-785-2500 · preventad@research.baycrest.org
Always discuss trial participation with your own doctor first.
| Rotman Research Institute at Baycrest | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07212504